Classification & Assessment in Psychiatry · Paper A
Rapid cycling bipolar disorder
This label matters because it changes which drugs get favoured once mood swings turn frequent rather than occasional. Rapid cycling is defined purely by episode FREQUENCY, not by episode severity or type. For example, imagine a patient with four or more distinct mood episodes within a single year, that frequency alone meets the definition, whether the episodes are manic, depressive, or mixed. In practice, confirm distinct episodes and review factors that can accelerate cycling.
Rapid cycling means four or more mood episodes in a year, more frequent than typical bipolar disorder. Antidepressants can induce or worsen cycling in some patients, so their role needs careful review. Hypothyroidism and substance use are recognised contributors. Picture cycling accelerating after an antidepressant is introduced while thyroid tests also show hypothyroidism: both treatment and reversible contributors need reassessment. In practice, investigating thyroid function and substance use is part of management, not just adjusting mood stabilisers.
Bipolar disorder (a mood condition with episodes of both /hypomania and depression) usually runs a course of a few episodes over many years. Rapid cycling is not a separate diagnosis; it is a course specifier bolted onto bipolar disorder when episodes come thick and fast. The specifier exists because the pace of illness changes the whole management conversation: a patient having one manic episode every three years is managed very differently from a patient swinging between mania and depression every few weeks, even though both technically have bipolar disorder.
The formal definition is four or more distinct mood episodes (manic, hypomanic, depressive, or mixed) within a single 12-month period. Each episode must meet full criteria for that episode type, and episodes are usually separated by either a period of partial or full remission lasting at least two months, or by a switch to an episode of the opposite polarity.
For example, imagine a patient who has a manic episode in January, drops into a depressive episode by March, swings back to hypomania in July, and is depressed again by November. That is four episodes in a year, so the rapid cycling specifier applies regardless of how severe any single episode was. This matters clinically because rapid cycling is not simply "more severe" bipolar disorder that needs a stronger version of the usual treatment; it is a course pattern with its own set of reversible contributors that need actively hunting for.
Several factors are recognised as pushing a patient toward this frequent-episode pattern. Antidepressant use is one of the best-known: in some patients with bipolar disorder, antidepressants can trigger a switch into or accelerate cycling between poles, so their continued use is reviewed carefully once rapid cycling is suspected. Hypothyroidism (an underactive thyroid gland producing too little thyroid hormone) is another recognised contributor, and thyroid function tests are a standard part of the work-up. Rapid cycling is also reported more often in women than men, and substance misuse and poor treatment adherence can both destabilise the cycle further.
Suppose a patient's cycling frequency doubles shortly after starting an antidepressant for a depressive episode. The correct next step is to question that drug's ongoing role, not just to add another mood stabiliser on top. In this worked case, the clinician would check thyroid function, review whether the antidepressant is being used as monotherapy against guidance, screen for substance use, and only then decide whether additional mood-stabilising treatment is genuinely needed once the reversible drivers have been addressed.
Not every patient with rapidly shifting mood has rapid cycling bipolar disorder as defined above. Borderline personality disorder produces marked mood instability, often shifting within hours in response to interpersonal triggers, which is a fundamentally different, faster and more reactive pattern than the days-to-weeks episodes required for the rapid cycling specifier. Cyclothymia involves chronic, low-grade mood fluctuation that never reaches the full severity threshold for a hypomanic or depressive episode, so by definition it cannot qualify as rapid cycling, which requires full episodes. Substance-induced mood swings, particularly from stimulant use, can mimic a cycling pattern but resolve once the substance is stopped rather than persisting as an underlying illness course. Clinicians should also rule out a comorbid personality disorder or substance-induced mood disorder, since these can mimic a rapid-cycling course without truly being one.
Diagnosis rests on a careful mood history, ideally supported by a mood diary charting episode onset, offset, and polarity over the preceding year, since patients often struggle to recall exact episode boundaries from memory alone. Investigation should include thyroid function tests to screen for hypothyroidism, a review of current and recent medications (especially antidepressants and corticosteroids), and a substance use history.
Management starts by treating the current episode according to standard bipolar disorder guidance, following principles set out in NICE guidance on bipolar disorder: an antimanic agent for a manic episode, and a mood stabiliser or antipsychotic combination for a depressive episode, always checking that an antidepressant is not being used as monotherapy. Alongside this, the clinician reviews and where appropriate withdraws or tapers antidepressants, treats any hypothyroidism found, and addresses substance use and adherence problems, since untreated versions of any of these can keep driving the cycle. For long-term prophylaxis, valproate (a mood stabiliser also used for epilepsy) or lamotrigine (a mood stabiliser particularly effective against depressive relapse) are often preferred over lithium in rapid cycling, since lithium alone can be less effective at controlling this frequent-episode pattern, although some patients still respond well to it and it remains a reasonable first-line option to trial. Combination therapy is common in practice, and referral to a specialist mood disorders service is reasonable when cycling continues despite these first-line adjustments, per Maudsley Prescribing Guidelines advice on treatment-resistant bipolar disorder.
The classic trap is a vignette where a patient's cycling frequency has clearly worsened after antidepressant initiation, and the tempting wrong answer is to increase or add another mood stabiliser. The exam wants you to spot and stop the antidepressant, and check thyroid function, before reaching for more medication.
Rapid cycling bipolar disorder means four or more full mood episodes in 12 months, and clinically it should prompt a two-track response, treat the episode in front of you while actively investigating and correcting reversible drivers like antidepressant use, hypothyroidism, and poor adherence, rather than simply escalating the existing mood stabiliser.